The coactivation of STAT3 and NOTCH1 is associated with cisplatin resistance in HNSCC, and the simultaneous downregulation of STAT3 and NOTCH1 using siRNA enhances chemosensitivity in breast cancer [21,22]. This evidence concerns the gene STAT3 and breast cancer.